UCB, Dr. Reddy's, Others Settle Keppra Litigation
Belgian pharmaceutical company UCB has struck settlement deals with Mylan Pharmaceuticals Inc., Dr. Reddy's Laboratories Inc. and Cobalt Pharmaceuticals Inc., resolving pending patent litigation in Georgia over UCB's epilepsy treatment Keppra....To view the full article, register now.
Already a subscriber? Click here to view full article